Incidence of adverse event of special interests (AESIs) that occur within 4 days of study drug administration;Incidence of adverse event of special interests (AESIs) that occur within 4 days of study drug administration;Concentrations of REGN10933 in serum over time;Concentrations of REGN10987 in serum over time;Incidence of adverse event of special interests (AESIs) that occur within 4 days of study drug administration;Incidence of adverse event of special interests (AESIs) that occur within 4 days of study drug administration;Incidence of adverse event of special interests (AESIs) that occur within 4 days of study drug administration;Incidence of adverse event of special interests (AESIs) that occur within 4 days of study drug administration

Incidence of adverse event of special interests (AESIs) that occur within 4 days of study drug administration;Incidence of adverse event of special interests (AESIs) that occur within 4 days of study drug administration;Concentrations of REGN10933 in serum over time;Concentrations of REGN10987 in serum over time;Incidence of adverse event of special interests (AESIs) that occur within 4 days of study drug administration;Incidence of adverse event of special interests (AESIs) that occur within 4 days of study drug administration;Incidence of adverse event of special interests (AESIs) that occur within 4 days of study drug administration;Incidence of adverse event of special interests (AESIs) that occur within 4 days of study drug administration